Related by context. All words. (Click for frequent words.) 72 ToxCast ™ 70 ToxCast 62 CellCiphr 62 StemEx 62 RiVax 62 mertansine 62 SBIR Grant 61 Protexia ® 61 human microdosing 60 OMP #M# 60 tubulin inhibitor 60 preclinically 60 therapeutic monoclonal antibody 60 Varespladib 60 Onconase 59 Prodarsan ® 59 non nucleoside HCV 59 non nucleoside 59 R#/MEM # 59 synDNA TM 59 adrenergic regulation 59 Bayer HealthCare Onyx Pharmaceuticals 59 torezolid phosphate 59 preclinical efficacy 59 ONCONASE R 59 Lenocta 59 PrevOnco ™ 59 oral taxane 59 Anacetrapib 59 IL# PE#QQR 59 Phase IIB 59 Curaxin 59 ORADUR ADHD 59 PSMA ADC 58 GLP toxicology studies 58 Radilex 58 Neugene 58 cediranib 58 HQK 58 Vaxfectin TM 58 Phase IIA 58 therapeutic monoclonal antibodies 58 trastuzumab DM1 58 YONDELIS 58 rPA anthrax vaccine 58 investigational protease inhibitor 58 multicenter Phase II 58 Phase Ib II 58 Tesmilifene 58 Immunotherapeutic 58 CBLC# 58 Virdante 58 trastuzumab DM1 T DM1 58 indibulin 58 BioMarck 58 neuronal nicotinic receptors NNRs 58 HuLuc# 58 Archexin 58 Eribulin 58 Pertuzumab 58 phase IIa clinical 58 Panzem R NCD 58 optimal dosing regimens 58 acyclovir Lauriad R 58 riociguat 58 rxRNA 58 Fabry Disease 58 SinuNase ™ 58 endothelin antagonist 58 Aplidin 58 vitro dissolution 57 preclinical toxicology 57 Trofex 57 Protexia R 57 TransVax tm 57 JAK2 inhibitor 57 Phase IIb clinical trials 57 CVac 57 StemEx R 57 PLK1 SNALP 57 PET tracers 57 Exherin TM 57 NP2 Enkephalin 57 Proellex TM 57 Trandolapril 57 Angiotensin Converting Enzyme 57 Pimavanserin 57 Spiegelmer ® 57 lucinactant 57 NPC 1C 57 CEQ# 57 CCR5 mAb 57 HCV protease inhibitors 57 Surfaxin LS 57 anti CD3 antibody 57 forodesine 57 GRNVAC1 57 AKT inhibitor 57 ALK inhibitors 57 vivo preclinical 57 ADVANCE PD 57 phase Ib 57 Genz # 57 ganaxolone 57 PEG SN# 57 targeted radiotherapeutic 57 NEUGENE 57 Civacir 57 Phase 2a clinical trials 57 Mipomersen 57 plasmid DNA vaccine 57 IMA# 57 HepDirect prodrug 57 inhaled AAT 57 GSK# [002] 57 USL# 57 midstage trials 57 GW# [003] 57 siRNA therapeutics 57 MAGE A3 ASCI 57 alvespimycin 56 Solazed 56 Anthim 56 Myocet 56 torezolid 56 ASPIRE HIGHER 56 oral prodrug 56 Urocidin 56 TransVax TM 56 beta 1a 56 biocatalytic 56 GALNS 56 ospemifene 56 PHX# 56 SynCon 56 incyclinide 56 Solulin 56 orally dosed 56 Valortim ® 56 NABTT 56 Dacogen decitabine 56 Muraglitazar 56 recombinant biopharmaceutical 56 Phase #b/#a clinical 56 liposomal formulation 56 elotuzumab 56 sitaxsentan 56 KSP inhibitor 56 phase IIb trial 56 pDNA vaccines 56 Protectan CBLB# 56 biologic therapeutics 56 tolevamer 56 deforolimus 56 DispersinB ® 56 Cerashield ™ 56 ENDEAVOR clinical 56 DermaVir 56 Trastuzumab DM1 56 Ozarelix 56 RhuDex 56 optical biosensors 56 depsipeptide 56 receptor tyrosine kinase inhibitor 55 Panzem 55 recombinant antibodies 55 PrevOnco 55 GVAX ® 55 Cand5 55 Pafuramidine 55 anticancer compound 55 budesonide foam 55 Diamyd ® 55 MorphoSys proprietary 55 novel histone deacetylase 55 EGEN 55 Small Molecule 55 ThGRF 55 BAL# [002] 55 proteasome inhibitor 55 HuMax EGFr 55 Prodarsan R 55 PDE4 inhibitor 55 Xanafide 55 Exelixis XL# 55 PRESEPT 55 Elagolix 55 TriGrid 55 OvaRex R 55 immatics 55 Qualified Therapeutic Discovery 55 radiolabeled TM# 55 Pancreate 55 selective immunoproteasome inhibitor 55 tiapamil 55 multicenter Phase 55 OncoVex 55 Anavex #-# 55 Allovectin 7 55 transmucosal delivery system 55 Arranon 55 thorough QT 55 Cethrin R 55 Erimos 55 Tykerb lapatinib 55 neratinib 55 bioscavenger 55 antisense inhibitor 55 NEUMUNE 55 Starpharma dendrimer 55 BiTE 55 IIa clinical 55 anticancer therapeutics 55 Cathepsin S 55 prostone 55 Solorel 55 metabonomics 55 midstage clinical 55 enzyme inhibitor 55 Vidofludimus 55 Tarvacin TM 55 Evoltra ® 55 Phase #/#a 55 tezampanel NGX# 55 Homspera TM 55 ARRY # 55 Iloperidone 55 BAY #-# 55 BrachySil TM 55 Pazopanib 55 eligen 55 Nexavar sorafenib tablets 55 PRTX 55 HuMax CD4 55 alkylating agent 55 oral salmon calcitonin 55 afamelanotide 55 antitumour 55 Systemic Delivery 55 ImQuest 55 bardoxolone 55 Cetrorelix 55 Dalbavancin 55 BEMA Granisetron 55 retaspimycin 55 OvaRex ® MAb 55 Peer Reviewed Medical 55 Intarcia 55 telomerase activator 55 IIa trials 55 tranilast 54 MKC# MKC# PP 54 AAG geldanamycin analog 54 Transfection Reagent 54 vivo validation 54 NADiA 54 oral proteasome inhibitor 54 Aviptadil 54 Allovectin 7 R 54 Aspergillus nidulans 54 Perceiva 54 bortezomib Velcade 54 TransMID 54 DXL# 54 PANVAC VF 54 midstage studies 54 immunotoxins 54 Tarvacin Anti Viral 54 Successfully Completes Phase 54 generation purine nucleoside 54 TransVax ™ 54 immunotherapeutic vaccine 54 randomized multicenter trial 54 allogeneic cell 54 Aganocide 54 JAK3 inhibitor 54 Fodosine 54 Prodarsan 54 Deforolimus 54 Aflibercept 54 Inhalation Solution 54 LUX Lung 54 EGS# 54 phase IIa 54 Oral Insulin 54 Granulocyte Colony Stimulating Factor 54 Vaxfectin 54 Fenretinide 54 Fast Track Status 54 STEDESA 54 Phase 1a clinical 54 TLR agonists 54 MyVax 54 WRAIR 54 biodegradable nanoparticles 54 Phase III ADT 54 VitiGam 54 LHRH antagonist 54 potent anticancer 54 radiolabeling 54 Kevetrin ™ 54 vivo potency 54 Saforis 54 receptor inhibitor 54 Transformational Medical 54 Valtropin 54 OLEPTRO 54 Nanoemulsion 54 NITD# 54 oral PTH 54 OHR/AVR# 54 BACcel 54 Phase lll 54 EP #R 54 Aethlon Hemopurifier R 54 antiangiogenesis 54 polymerase inhibitor 54 ChronVac C ® 54 STTR grant 54 VivaGel ™ 54 SBIR Phase 54 Phase Ib study 54 Phase IIa trials 54 DUROS 54 TBC# 54 Diamyd R 54 AEG# 54 OncoGel 54 Zemplar Capsules 54 PEARL SC 54 multicenter dose escalation 54 Achieves Primary Endpoint 54 BioVant 54 dalbavancin 54 IND submission 54 CytoFabTM 54 antifibrotic 54 ActivX 54 Anidulafungin 54 Alferon N 54 FOLOTYN ® 54 molecular profiling 54 oral antiviral 54 proteasome inhibition 54 Tarmogen 54 A3 adenosine receptor 54 Phase Ib clinical trials 54 CELVAPAN H#N# 54 UPLYSO 54 TRIST study 54 PEGylated interferon 54 Monoclonal antibody 54 R#/MEM 54 PATH MVI 54 GeoVax vaccine 54 HuMax 54 Tarceva TM 54 DP VPA 54 glucokinase activator 54 OncoVEX 54 REGiMMUNE 54 lipopeptide 54 assessing T DM1 54 sirtuin modulators 54 validate biomarkers 54 Alequel ™ 53 Corlux 53 SBIR Phase II 53 injectable formulations 53 Traficet EN 53 Azacitidine 53 Neumune 53 Prolongs Survival 53 URG# 53 Phase Ib clinical 53 JAK inhibitor 53 Chemical Entity NCE 53 cathepsin K inhibitor 53 non nucleoside inhibitor 53 IMiD 53 Tarvacin 53 Cethromycin 53 anticoagulant reversing agent 53 MAQC 53 Cellcept 53 SEPET TM 53 New Chemical Entities 53 Tasimelteon 53 Temsirolimus 53 immunomodulator 53 faropenem 53 LBH# 53 delipidation 53 novel oral anticoagulant 53 CAMPATH 53 dosing cohort 53 RELOVAIR ™ 53 flavopiridol 53 KineMed 53 drug ISA# 53 VersaFilm 53 JZP 53 CDDO Im 53 NO# [002] 53 Daclizumab 53 ITAX 53 Syncria albiglutide 53 RNAi Therapeutic 53 ibritumomab tiuxetan 53 SparVax TM 53 mTOR inhibition 53 Camvia 53 Monoclonal Antibody 53 Alfacell proprietary ribonuclease 53 Ixabepilone 53 Tolamba 53 Campath ® 53 IMiDs 53 oral NKTR 53 SNT MC# 53 CRACM 53 vidofludimus 53 Phase III Clinical Trials 53 TACI Ig 53 Protectan 53 ascending dose 53 Cellerant 53 Zybrestat 53 Maribavir 53 HepeX B TM 53 AeroLEF TM 53 Precision Antibody 53 confirmatory clinical 53 Harry Palmin President 53 miconazole Lauriad R 53 GVAX Pancreas Vaccine 53 ORENCIA R 53 REMINYL ® 53 Thiovir 53 FTIs 53 novel peptides 53 Pharmos pipeline 53 XOMA 3AB 53 murine models 53 albiglutide 53 mesylate 53 Etravirine 53 Talotrexin 53 CAMMS# 53 TBC M4 53 entity NCE 53 Adult Stem Cell Therapy 53 Febuxostat 53 HuCAL antibodies 53 subcutaneous PRO 53 AZILECT ® 53 Alinia 53 registrational trials 53 oncolytic virus therapies 53 PF # [002] 53 XmAb# 53 Crizotinib 53 LibiGel ® 53 Actimmune ® 53 II SBIR 53 Telatinib 53 rPA Anthrax Vaccine 53 LUMINATE 53 Oral Calcitonin 53 interferon beta 1b 53 EXPLORE Xa 53 postapproval 53 Phase IIIb study 53 OLYMPIA registry 53 Syntonix 53 Phase 2a trial 53 PREOS R 53 Guanilib 53 dSLIM 53 Multimeric 53 phase IIb clinical 53 ganetespib 53 Belerofon 53 apricitabine ATC 53 NIH SBIR 53 SPL# Gel vaginal microbicide 53 samalizumab 53 Universal Flu Vaccine 53 Olaparib 53 Vidaza azacitidine 53 Glufosfamide 53 Silodosin 53 Protease Inhibitor 53 Nanobody 53 DepoVax TM 53 Imvamune 53 fumagillin nanoparticles 53 Celator 53 cyclophilin inhibitors 53 DPOLT 53 Alvesco R 53 Phase 1b clinical trials 53 Teplizumab 53 Litx 53 SAR# [004] 53 miRNA biomarkers 53 adecatumumab MT# 53 radiolabelled 53 GLP1 agonist 53 tramiprosate Alzhemed TM 53 HCD# [002] 53 BRAF inhibitor 53 acting muscarinic antagonist 53 Ostabolin C TM 53 IMC #B 53 oral methylnaltrexone 53 PNT# 53 NV1FGF 52 Parathyroid Hormone 52 topical gel containing 52 PN# [001] 52 Vidaza R 52 Angiocept 52 huC# DM4 52 selective androgen receptor modulators 52 Zebinix R 52 dexpramipexole 52 Safinamide 52 HIV integrase inhibitor 52 TTF therapy 52 defensin mimetic antibiotic 52 Elusys 52 vemurafenib 52 Completes Patient Enrollment 52 Nitazoxanide 52 PNP inhibitor 52 SUCCEED trial 52 modENCODE 52 phase IIb study 52 Factor VIIa 52 PTK# 52 canagliflozin 52 LCP AtorFen 52 quantitative PCR qPCR 52 APEX PD 52 Mycophenolate Mofetil 52 telomerase activators 52 nalbuphine ER 52 Pervasis 52 RGB # 52 Panzem ® 52 Cintredekin Besudotox 52 Recombinant Human 52 CDAD Clostridium difficile 52 HuMax TAC 52 Dasatinib 52 TransMID TM 52 IMPACT DCM 52 MKC# MT 52 MMP inhibitors 52 Gleevec imatinib mesylate 52 CYT# QbG# 52 SparVax ™ 52 Liprotamase 52 Initiate Phase 52 Protein Structure Initiative 52 Galenea 52 Phase IIa proof 52 Taligen Therapeutics 52 nitric oxide donating prostaglandin 52 Edurant 52 REG2 52 PharmaNova 52 SBIR grant 52 including eniluracil ADH 52 Phase III Clinical Trial 52 balsalazide tablet 52 macitentan 52 Cancidas 52 Alzhemed TM 52 TKM Ebola 52 REP# 52 Corgentin 52 Sumatriptan Succinate 52 Therapeutic Vaccine 52 TÎ ² 4 52 Naproxcinod 52 LymphoStat B 52 Provenge prostate cancer 52 hepatitis B vaccine Heplisav 52 Benazepril 52 denosumab oncology 52 phase IIIb 52 HyperAcute 52 Valortim 52 volociximab 52 alefacept 52 bioassays 52 BRIM3 52 ENCODE 52 vivo molecular imaging 52 Scopus Affiliation Identifier 52 Voraxaze 52 diagnostic biomarker 52 tkRNAi 52 overactive bladder AA# 52 Phase 1a 52 NIH NIAID 52 Amrubicin 52 Bioral Amphotericin B 52 rhFVIIa 52 vapreotide acetate 52 Enobia 52 controlled multicenter Phase 52 Shigamabs ® 52 EV# vaccine 52 Aptamer 52 masitinib 52 CRMD# 52 Affinitak 52 humanised monoclonal antibody 52 Noxafil 52 Vectibix panitumumab 52 rALLy clinical trial 52 Personalized Immunotherapy 52 PORxin TM platforms 52 Valdoxan 52 MEND CABG II 52 CompoZr 52 staphylococcal vaccine 52 PFO migraine 52 Crofelemer 52 CIP TRAMADOL ER 52 novel therapeutic antibodies 52 ACCLAIM II 52 Panzem R 52 TRISENOX ® 52 oral opioid modulator 52 WHO Prequalification 52 PDL# 52 Optimata 52 Elvitegravir 52 Apoptone 52 corticosteroid dexamethasone 52 Bazedoxifene 52 CCR5 inhibitor 52 AERAS-#/Crucell Ad# 52 Pivotal Phase III 52 reslizumab 52 MT#/MEDI-# 52 generation HCV protease 52 Initiate Clinical Trial 52 antiobesity 52 Phase #/#a clinical 52 Liposomal 52 glatiramer 52 NHGRI Large Scale 52 HCV polymerase inhibitor 52 SinuNase TM 52 Calcium Acetate 52 nucleotide analogue 52 molecular entities NMEs 52 integrase inhibitor 52 Neovastat 52 Etubics 52 Omnitarg 52 Uplyso 52 cannabinor 52 Pivotal Phase 52 IIa clinical trials 52 IV Busulfex 51 Inhaled nitric oxide 51 Meets Primary Endpoint 51 novel peptide 51 HCl capsules 51 BioSeek 51 lorvotuzumab mertansine 51 Cardio Vascu Grow 51 Nexavar sorafenib 51 ATL# [002] 51 PI3K inhibitor 51 OMNARIS Nasal Spray 51 NEUGENE R 51 ZEVALIN ® 51 NexACT ® 51 Iressa gefitinib 51 rPA 51 Pandemic Influenza Vaccine 51 Peptidomics 51 GeneICE 51 Vfend 51 registrational Phase 51 peptide antigens 51 antigen sparing 51 Initiates Clinical 51 Phase IIb III 51 registrational 51 Tezampanel 51 AzaSite Plus 51 FOR FURTHER INFORMATION ABOUT 51 Therapeutic Discovery Project 51 biodefense pathogens 51 QTDP program 51 ZFP Therapeutic 51 OLpur TM MD 51 DiaKine 51 Cefazolin 51 Dapagliflozin 51 Eli Lilly Cymbalta 51 CTLA4 Ig 51 Vimpat R 51 Accelerated Approval 51 Fondaparinux 51 Panflu 51 BRAF inhibitors 51 HTS assay 51 fluoroquinolone antibiotic 51 JAK Inhibitor 51 Desmoteplase 51 isavuconazole 51 EndoTAG TM -1 51 tremelimumab 51 multicenter phase 51 DEEP AF 51 Saquinavir 51 BENLYSTA ® 51 Listeria vaccine 51 EVIZON TM 51 Locked Nucleic Acid LNA 51 antiangiogenic agent 51 cardio renal 51 RECOTHROM R 51 Phase IIIb clinical 51 cytokine refractory 51 Juvaris BioTherapeutics 51 GRNCM1 51 Phase 2a Clinical Trial 51 Ataluren 51 Lu AA# 51 CCR5 receptor antagonist 51 Canvaxin 51 delivery polymer matrix 51 JAK3 51 extraction SPE 51 Mpex 51 Orphan Status 51 Dendreon Provenge 51 KNS # 51 Actilon 51 daptomycin 51 VitiGam TM 51 bavituximab monotherapy trial 51 radezolid 51 HemoGenix 51 Sym# 51 Qutenza TM 51 HPCGG 51 neuronal nicotinic receptor NNR 51 nanocarrier 51 Grower Harvester 51 DepoVax 51 topical ophthalmic 51 AP# [003] 51 CholeraGarde R 51 monoclonal antibody mAb 51 registrational trial 51 EC Cysteamine 51 enzastaurin 51 Abiraterone 51 Initiates Enrollment 51 Ganciclovir 51 phosphatidylserine PS targeting 51 Phase #b/#a 51 Initiates Clinical Trial 51 HuMax CD# 51 nonviral 51 ISENTRESS raltegravir 51 Arzerra TM 51 zileuton 51 EndoTAG TM 51 nanoviricides 51 omacetaxine mepesuccinate 51 Emezine 51 fostamatinib disodium 51 Altastaph 51 synthetic genomics 51 Phase 2b clinical trials 51 randomized controlled Phase 51 VALSTAR 51 GSK# [001] 51 ritonavir boosted danoprevir 51 Bevasiranib 51 Knockout Mouse 51 Thrombin 51 2DG 51 CRD5 51 phase Ib clinical 51 Fc fusion protein 51 Phase IIIb 51 resVida ® 51 GastroPlus 51 GRN# 51 Akonni 51 AZILECT R 51 Lipoxen 51 TapImmune 51 HepaLife 51 Keryx Biopharma 51 blinded randomized placebo controlled 51 PHASE III 51 QNEXA ® 51 Arsenic trioxide 51 HPTN 51 outlicensed 51 targeting CD# 51 ASONEP 51 Genome sequencing 51 Oncotype DX colon cancer 51 IMVAMUNE TM 51 vascular thrombosis 51 CyPath ® 51 REGEN trial 51 initiated Phase Ib 51 Valproic acid 51 Certican 51 AIMM trial 51 toenail onychomycosis 51 human microbiome 51 Xcellerated T Cells 51 5 fluorouracil leucovorin 51 EDRN 51 Insegia 51 perampanel 51 Cleveland BioLabs 51 BLP# Liposome Vaccine 51 OTCBB PYTO 51 Ibis T# 51 ENESTnd 51 Sorafenib Nexavar 51 FLUPAN 51 IRS Qualifying Therapeutic 51 dose cohort 51 tPEMF tm 51 FoldRx 51 phase 2a 51 Moxifloxacin 51 Clofarabine 51 immunotoxin 51 Melphalan 51 Lipofen 51 bioinformatic analyzes 51 Zenvia Phase III 51 paromomycin 51 Homspera 51 VivaGel TM 51 protein microarrays 51 recurrent metastatic ovarian cancer 51 H#N# antigen 51 lipid particle 51 Orphan Designation 51 gamma secretase inhibitor 51 MabThera rituximab 50 RSD# oral 50 Firazyr 50 IMGN# 50 DEB# 50 XYOTAX TM 50 BLA submission 50 INS# [001] 50 cGMP manufacture 50 HepeX B 50 Initiated Phase 50 Velcade bortezomib 50 synthetic siRNAs 50 Tigecycline 50 Tarvacin Anti Cancer 50 Tr DNA 50 Granted Orphan Drug 50 anti tubercular 50 Sustiva efavirenz 50 Virulizin ® 50 Oglemilast 50 Cytomegalovirus CMV 50 EndoBiologics 50 ongoing Phase IIIb 50 lixivaptan 50 Cyclosporin 50 Optimer Pharma 50 Vaxfectin R 50 deCODE biostructures 50 OTCBB CVBT 50 MVA BN R 50 Diamyd r vaccine 50 dose escalation clinical 50 ursodiol 50 double blinded placebo 50 PD LID 50 SUVN 50 MOVIPREP R 50 hepatitis B immune globulin 50 Nanotherapeutics 50 Oncaspar 50 recombinant influenza 50 ImmunoCellular Therapeutics 50 Ophthotech 50 MVA MUC1 IL2 50 radiotracers 50 PRECISE Trial 50 maturation inhibitor 50 DiamondFlo TM 50 PhytoMedical 50 NSF SBIR 50 Lubiprostone 50 tramiprosate ALZHEMED TM 50 Multiple Ascending Dose 50 Gleevec Glivec 50 recombinant subunit vaccine 50 dose escalation Phase 50 adenoviral vectors 50 AE# vaccine 50 Phase 1b trial 50 oglemilast 50 HepaGam B 50 5 HT3 antagonist 50 miglustat 50 lentiviral 50 Crucell PER.C6 ® 50 AmpliChip 50 Lopinavir 50 Gleevec resistant 50 EpiCeram 50 NOX E# 50 cilengitide 50 investigational hepatitis B 50 formerly LymphoStat B 50 S/GSK# 50 protein biochips 50 GA GCB 50 Cancer Genome Atlas 50 Pivotal Study 50 Human Microbiome Project 50 Levetiracetam 50 SCIB1 50 Davanat 50 HepDirect R 50 MDS AML 50 PXD# 50 CMV vaccine 50 Ranolazine 50 Piperacillin 50 Annamycin 50 Anticancer Agent 50 Neuvenge 50 Microplasmin 50 gepirone ER 50 FASgen 50 DiaPep# 50 randomized crossover 50 IIa trial 50 Polymer Microspheres 50 NSABP 50 Orphan designation 50 TRANSDUR Bupivacaine 50 molecularly targeted therapies 50 small molecule thrombopoietin 50 Adenosine Therapeutics 50 humanized monoclonal antibodies 50 ongoing Phase 1b 50 Montelukast 50 phase IIb 50 RhuDex ® 50 NEUGENE antisense 50 Crofelemer budesonide foam 50 carbapenem 50 Teysuno 50 Fortical R 50 LEAPS TM 50 SparVax 50 Oral Spray 50 Betaferon R 50 ENRICH trial 50 Potelligent Technology 50 MAA submission 50 multicenter randomized Phase 50 oral antiplatelet agent 50 TRAIL receptor antibodies 50 virology immunology 50 HBV vaccine 50 Zerenex 50 Dr. Pasinetti 50 ZFP Therapeutics 50 Initiates Phase II 50 IIb clinical trial 50 adeno associated viruses 50 GelSite polymer 50 StaphVax 50 RNA amplification 50 UCB Keppra 50 confirmatory pivotal